Search for a trial

Multicenter, open-label study to assess the effects of Certolizumab Pegol on the reduction of anterior uveitis flares in axial spondyloarthritis subjects with a history of anterior uveitis (C-view)

Primary objective:The primary objective of the study will be to demonstrate the effect of CZP treatment on the reduction of AU flares in subjects with both active axSpA and a documented history of AU.Secondary objective:The secondary objectives of…

A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.

The objective of the study is to compare conventional therapy with biological therapy in patients with early rheumatoid arthritis.

A Postmarketing, Multicenter, Longitudinal, Prospective, Pharmacokinetic, Phase 1b Study in Pregnant Women with Chroinc Inflammatory Diseases Treated with Cimzia (Certolizumab Pegol)

PrimaryTo assess systemic CZP exposure across the course of pregnancy in study participants with chronic inflammatory diseases.Secundary To assess the formation of anti-CZP antibodies across the course of pregnancy To assess the safety of CZP in…